ALYATEC will be present at the next annual congress of the European Academy of Allergy and Clinical Immunology.

It will be a particular edition since a physical part of the congress will be organised in the city of Krakow (Poland) from 10th  to 12th July 2021 and the other part will be digital.

Pr. de Blay, medical expert of ALYATEC, will present results with regard to the clinical study conducted for Regeneron Pharmaceuticals with cat-asthmatic patients.

Dr. A. Gherasim, allergist in ALYATEC, will present clinical data from an internal clinical validation study performed in the ALYATEC environmental exposure chamber with birch pollen rhinitis patients.



1- ePoster Discussion Session 05 Novel insights in allergic diseases on pathophysiology and treatment of allergic diseases
Late Breaking electronic Poster Discussion Session – Monday, 12 July 2021 – 12:30-13:30

#1000 A single dose of REGN1908-1909 reduced the rate of early asthma responses, chest symptoms and rescue medication use in cat-allergic subjects with mild asthma for up to 3 months following a controlled cat allergen challenge: A phase 2, randomized, double-blind, placebo-controlled study

2- ePoster Eear-Nose-Throat
#739 Evaluation of nasal response to birch allergen in ALYATEC environmental exposure chamber as compared to nasal provocation test


Feel free to contact us if you want more information !